MGCD-265

MGCD-265

[bis(2-cyanoethyl)-N,N',N'',N'''-tetrakis[2-[(2-cyanoethyl)amino]ethyl]-29H,31H-phthalocyaninetetrasulphonamidato-N29,N30,N31,N32]copper

4-[(E)-2-(1,3-dimethylimidazo[4,5-b]quinoxalin-3-ium-2-yl)ethenyl]-2-methyl-3-phenyl-1,2-oxazol-5-one,4-methylbenzenesulfonate

trioleic acid, triamide with N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]ethane-1,2-diamine (1:1)

ML 265

bis[4-hydroxy-6-[(2-hydroxy-5-methylphenyl)azo]-3-[(2-hydroxy-3-nitro-5-sulphophenyl)azo]naphthalene-2-sulphonato(4-)]chromate(5-)

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

Ethyl 3-(5-methyl-1H-indazol-3-yl)propanoate

2-{1-[(Benzyloxy)carbonyl]azetidin-3-yl}propanoic acid

2-(Bromomethyl)-4-(difluoromethyl)-5-methoxypyridine-3-methanol

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

N-(5-(N-(2-(7-oxofuro[2,3-c]pyridin-6(7H)-yl)ethyl)sulfamoyl)thiazol-2-yl)acetamide

N-(2-(5-cyclopropyl-3-(pyrazin-2-yl)-1H-pyrazol-1-yl)ethyl)-1H-indole-3-carboxamide

N-cyclopentyl-2-cyclopropyl-N-(2-(3-(pyridin-4-yl)-1H-pyrazol-1-yl)ethyl)acetamide